Robotic-Assisted Neurosurgery System Market Size, Share, and Trends Analysis - Global - 2025-2031 - Includes: Capital Equipment Market, Services and Maintenance Revenue Market

Global Robotic-Assisted Neurosurgery System Market Report, 2025 Edition

Executive Summary

The global robotic-assisted neurosurgery system market was valued close to 130 million dollars in 2024. Over the forecast period, the market is expected to grow at a compound annual growth rate of 14.5 percent and reach just under 330 million dollars by 2031.

This report covers capital equipment, disposables and related accessories, and service and maintenance revenue within the robotic-assisted neurosurgery segment. It quantifies units, average selling prices, market values, growth rates, and competitive shares. It also examines procedure volumes, market drivers and market limiters, recent mergers and acquisitions, clinical trends, and the strategic direction of leading competitors. Forecasts extend to 2032 and historical data are provided back to 2022.

Globally, neurosurgical facilities continue to expand the use of minimally invasive techniques. Robotic-assisted systems are becoming more common across cranial procedures as hospitals look to standardize operating rooms with technologies that enable greater precision, reduced complication rates, and improved efficiency. As more surgeons train on robotic platforms, and as clinical evidence continues to support procedural accuracy, adoption is expected to increase steadily across high-income and middle-income regions. While regulatory requirements remain strict, approvals are expanding, and more systems are entering the market.

Market Overview

Robotic-assisted neurosurgery systems support procedures that require high levels of accuracy, such as deep brain stimulation, tumor resection, biopsies, and stereotactic interventions. The technology is designed to improve procedural consistency and reduce the risk of neurological damage by guiding surgical instruments with millimeter-level precision.

From 2021 to 2024, global procedure volumes increased significantly as more hospitals integrated robotic systems into their neurosurgery departments. Procedure growth is expected to continue over the forecast period. While adoption of navigation systems remains higher, robotic systems are gaining momentum. The proportion of neurosurgeries performed using robotic assistance is projected to increase each year as technology evolves and surgeons become more experienced with these platforms.

Although capital system sales contribute meaningfully to the market, a growing share of revenue is generated through services and maintenance. This pattern is expected to continue as the installed base expands. Facilities typically purchase comprehensive service programs to ensure software updates, technical support, and system reliability.

Economic benefits also contribute to adoption. Robotic-assisted neurosurgery can reduce revision surgeries and shorten patient recovery times, lowering overall treatment costs for hospitals and payers. Hospitals increasingly incorporate robotic technologies to remain competitive, attract skilled neurosurgeons, and improve patient care.

Market Drivers

Clinical Benefits

Robotic-assisted neurosurgery systems offer substantial clinical and economic benefits. They support minimally invasive access to deep structures within the brain, where precision is critical. Robotic systems help surgeons achieve consistent trajectories, reduce intraoperative errors, and minimize soft-tissue disruption.

Short-term studies show time savings for complex procedures and equivalent procedure times for less complex cases. Reduced blood loss, fewer complications, and lower revision rates can shorten hospital stays and improve patient outcomes. These benefits support growing adoption among neurosurgeons, particularly in large academic centers.

Revenue from Service and Maintenance

Manufacturers benefit financially from a recurring revenue model. As the global installed base continues to expand, service and maintenance revenue will make up a larger share of total market value. Hospitals typically invest in long-term service contracts to maintain system performance, extend system life, and reduce downtime.

This recurring revenue strengthens market stability for manufacturers and creates long-term relationships with hospitals, supporting continued adoption.

Recruitment Competition

Hospitals compete for experienced neurosurgeons, and clinical talent often seeks institutions equipped with the latest surgical technologies. Installing a robotic-assisted neurosurgery system helps hospitals position themselves as leaders in innovation.

Robotic systems can also enhance institutional reputation, support marketing efforts, and improve patient perception. As competition grows across international markets, these benefits contribute to increased system installations.

Market Limiters

Cost of Using Robotic Systems

Robotic-assisted neurosurgery systems are more expensive than traditional navigation or manual tools. High capital costs limit adoption, particularly for small and midsize hospitals. In addition to upfront costs, hospitals must budget for ongoing service fees, software updates, and maintenance programs.

Budget allocation becomes more complex as hospitals evaluate systems across different clinical specialties. Larger companies may bundle robotic technology with implants or navigation platforms, but this does not eliminate the financial challenges associated with system procurement.

Training Period

Successful use of robotic neurosurgery systems requires specialized training. Surgeons may need multiple procedures to become fully proficient. Training programs often require proctors, technicians, and support staff.

Hospitals with limited personnel or high surgical workloads may be reluctant to adopt new technology that could slow operating room efficiency during the transition period. These learning-curve challenges can temporarily reduce procedural volume and limit adoption in certain regions.

Regulation

Robotic systems are subject to strict global regulatory requirements. Multiple federal, state, and international agencies oversee the approval process. Because neurosurgery involves the brain and central nervous system, regulatory scrutiny is particularly stringent.

Regulation often lengthens development cycles and delays product launches, affecting revenue and innovation. As more companies seek approval for new robotic systems or expanded indications, regulatory challenges are expected to remain a limiting factor.

Market Coverage and Data Scope

Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and ASPs.

Qualitative coverage: Growth trends, market limiters, competitive analysis, SWOT for leading competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.

Time frame: Base year 2024, forecasts to 2031, historical data 2021–2023.

Data sources: Primary interviews with orthopedic industry leaders, surgeon surveys, regulatory data, hospital procurement databases, and iData Research’s internal MedTech repository.

Method note: Market revenue is modeled as units × ASP, validated with procedural data and replacement cycle assumptions

Care settings include hospitals, orthopedic specialty centers, and ambulatory surgery centers (ASCs) across major global regions.

Markets Covered and Segmentation

Robotic-Assisted Neurosurgery by Revenue Type

Capital Equipment

Service and Maintenance Revenue

Competitive Analysis

Zimmer Biomet

Zimmer Biomet was the leading competitor in the global robotic-assisted neurosurgery system market in 2024. The company markets the ROSA ONE Brain system, a robotic platform that supports stereotactic neurosurgery procedures. The ROSA platform has gained significant traction due to its established clinical performance, strong reputation, and integration with surgical planning software.

Zimmer Biomet’s neurosurgery portfolio positions the company as a dominant player in this market and supports its presence in both cranial and spine-related robotic applications.

Synaptive Medical

Synaptive Medical held the second-leading position in 2024. The company’s product line includes Brightmatter Plan, Brightmatter Guide, and the Modus V robotic digital microscope. These systems work together to support surgical visualization, trajectory planning, and instrument guidance.

Synaptive’s focus on advanced imaging and digital workflow integration has strengthened its presence in hospitals that prioritize precision and high-quality visualization.

Medtronic

Medtronic ranked third in the global robotic-assisted neurosurgery system market. Its cranial robotic platform, Stealth Autoguide, received U.S. Food and Drug Administration clearance in 2019. Medtronic has a strong presence in surgical navigation, and the company leverages this position to support adoption of its robotic platform.

Medtronic’s strategic advantage lies in the integration of robotic systems with its navigation technology, allowing hospitals to combine guidance, planning, and robotic-assisted intervention within a unified ecosystem.

Technology and Practice Trends

Robotic-assisted neurosurgery is expanding beyond traditional stereotactic interventions. Increasingly, hospitals are adopting robotic platforms for biopsies, deep brain stimulation, tumor resections, and endoscopic neurosurgical applications. Integration with advanced imaging modalities is a key trend, enabling improved preoperative planning and intraoperative navigation.

Artificial intelligence is expected to play a growing role in image processing, surgical planning, and decision support. As AI-enabled tools become more common, robotic systems will benefit from automated trajectory selection, enhanced targeting accuracy, and predictive analytics.

Hospitals continue to standardize operating rooms with multi-purpose technologies. Systems that support both cranial and spinal neurosurgery are gaining popularity due to their cost efficiency and multi-specialty utility.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa

Why This Report

This report is designed for manufacturers, distributors, investors, consultants, and healthcare strategists who need accurate and detailed insight into the robotic-assisted neurosurgery system market.

It answers key questions such as:

What is driving the rapid adoption of robotic neurosurgery worldwide?

Which companies are investing in next-generation technologies?

How quickly will service and maintenance revenue grow as the installed base expands?

Which regions will experience the highest increase in procedure volumes?

How will regulatory trends and training requirements shape future adoption?

This report provides procedure-level data, device-level forecasts, competitive share analysis, and detailed commentary on technology trends that will shape the market through 2032.

About iData Research

iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.

Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.

Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.

Reports are available with flexible licensing to fit commercial, strategy, and investment workflows Show more